| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |